Dextech Medical AB Sustainability Reports
Dextech Medical AB is a Swedish biopharmaceutical research company specializing in urological oncology, primarily focused on developing drug candidates for prostate cancer. Its development portfolio includes carbohydrate-based molecules coupled with active substances to satisfy major unmet needs in clinical oncology.
Sector: Professional & technical services
Country: Sweden
Exchange: Nordic Growth Market
LEI: 549300O3OL7X6EWKLO53
FIGI: BBG006FYYD09
19 reports from 2011 to 2025
